As global leaders in high-titer viral stock production, Microbiologics supports the development and validation of vaccines, therapies, and assays for Mpox and other emerging viruses. In addition to viral stocks, Microbiologics offers custom assay services for a broad portfolio of viruses within our certified BSL-2 and BSL-3 biocontainment laboratories.

Our virus stocks are fully customizable and can be provided in live or inactivated formats. Microbiologics is skilled in making both wild-type and recombinant viruses at any scale. For drug discovery projects that require specific genetic alterations, Microbiologics offers reverse genetics services to produce viruses with the desired genetic sequences. All viral stocks are available with ddPCR quantification.

Microbiologics also offers a comprehensive menu of testing services to support antiviral drug and vaccine development for Mpox and other viruses. We take a consultative approach to each CRO partnership, applying our deep expertise to each unique testing challenge.

Find out more here or use the Request Information button below to contact Microbiologics directly.